Search

Your search keyword '"Kondo, Takayuki"' showing total 939 results

Search Constraints

Start Over You searched for: Author "Kondo, Takayuki" Remove constraint Author: "Kondo, Takayuki"
939 results on '"Kondo, Takayuki"'

Search Results

52. Regulation of Ascorbic Acid Biosynthesis in Plants

58. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy

59. Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy

60. Exploration of new positions for cabozantinib for advanced hepatocellular carcinoma in the latest real-world practice

62. Successful Identification of a Novel Therapeutic Compound for Hepatocellular Carcinoma Through Screening of ADAM9 Inhibitors

65. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells

71. Circulating plasmablasts and follicular helper T-cell subsets are associated with antibody-positive autoimmune epilepsy

72. Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice

74. Antiviral Compounds Screening Targeting HBx Protein of the Hepatitis B Virus

77. Controlling Major Portal Vein Invasion Progression during Lenvatinib Treatment by Carbon-Ion Radiotherapy in Patients with Advanced Hepatocellular Carcinoma

80. Analysis of hyperprogressive disease due to atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma

81. Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma

82. Use of ramucirumab for various treatment lines in real-world practice of patients with advanced hepatocellular carcinoma

83. Risk prediction of hepatic encephalopathy after molecular targeted therapy for hepatocellular carcinoma in patients with cirrhosis

84. MO5-1 Regorafenib in advanced HCC patients who were not included in the RESORCE trial: first interim analysis

85. Clinical features of exacerbation of portal vein thrombosis after discontinuation of anticoagulants

94. A case of hepatocellular carcinoma followed by asynchronous metastasis to the lung and thoracic spine following radical ablation treatment

95. Analysis of hyperprogressive disease due to atezolizumab combined with bevacizumab treatment in patients with advanced hepatocellular carcinoma

98. Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial

Catalog

Books, media, physical & digital resources